DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Kramar A, Bachelot T, Madrange T, Pierga JY, Kerbrat P, Espié M. et al
Trastuzumab duration effects within patient prognostic subgroups in the PHARE trial.
Ann Oncol 2014;
25: 1563-70
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.